Literature DB >> 12750472

Beta cell MHC class I is a late requirement for diabetes.

Emma E Hamilton-Williams1, Stephanie E Palmer, Brett Charlton, Robyn M Slattery.   

Abstract

Type 1 diabetes occurs as a result of an autoimmune attack on the insulin-producing beta cells. Although CD8 T cells have been implicated both early and late in this process, the requirement for direct interaction between these cells and MHC class I on the beta cells has not been demonstrated. By using nonobese diabetic mice lacking beta cell class I expression, we show that both initiation and progression of insulitis proceeds unperturbed. However, without beta cell class I expression, the vast majority of these mice do not develop hyperglycemia. These findings demonstrate that a direct interaction between CD8 T cells and beta cells is not required for initiation or early disease progression. The requirement for class I on beta cells is a relatively late checkpoint in the development of diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750472      PMCID: PMC164508          DOI: 10.1073/pnas.1131954100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.

Authors:  A Amrani; J Verdaguer; S Thiessen; S Bou; P Santamaria
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice.

Authors:  E E Hamilton-Williams; D V Serreze; B Charlton; E A Johnson; M P Marron; A Mullbacher; R M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

3.  Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients.

Authors:  S Prange; P Zucker; A M Jevnikar; B Singh
Journal:  Transplantation       Date:  2001-04-15       Impact factor: 4.939

4.  Non-obese-diabetic mice: immune mechanisms of pancreatic beta-cell destruction.

Authors:  Y Kanazawa; K Komeda; S Sato; S Mori; K Akanuma; F Takaku
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

5.  Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive.

Authors:  Shawn Winer; Hubert Tsui; Ambrose Lau; Aihua Song; Xiaomao Li; Roy K Cheung; Anastazia Sampson; Fatemeh Afifiyan; Alisha Elford; George Jackowski; Dorothy J Becker; Pere Santamaria; Pamela Ohashi; H-Michael Dosch
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

6.  Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.

Authors:  A Amrani; J Verdaguer; B Anderson; T Utsugi; S Bou; P Santamaria
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

7.  Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide.

Authors:  M Harada; S Makino
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

8.  Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.

Authors:  Osami Kanagawa; Ana Militech; Barbala A Vaupel
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

9.  Determinants of the selective toxicity of alloxan to the pancreatic B cell.

Authors:  W J Malaisse; F Malaisse-Lagae; A Sener; D G Pipeleers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis.

Authors:  J I Rotter; C E Anderson; R Rubin; J E Congleton; P I Terasaki; D L Rimoin
Journal:  Diabetes       Date:  1983-02       Impact factor: 9.461

View more
  46 in total

1.  In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition.

Authors:  Ying Li; Anthony W Frei; Ethan Y Yang; Irayme Labrada-Miravet; Chuqiao Sun; Yanan Rong; Magdalena M Samojlik; Allison L Bayer; Cherie L Stabler
Journal:  Biomaterials       Date:  2020-06-15       Impact factor: 12.479

Review 2.  Neuronal elements in the pathogenesis of type 1 diabetes.

Authors:  Hubert Tsui; Shawn Winer; George Jakowsky; H-Michael Dosch
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 3.  Viruses and cytotoxic T lymphocytes in type 1 diabetes.

Authors:  Ken T Coppieters; Matthias G von Herrath
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

4.  Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.

Authors:  James de Jersey; Sarah L Snelgrove; Stephanie E Palmer; Simon A Teteris; Arno Mullbacher; Jacques F A P Miller; Robyn M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

Review 5.  Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges.

Authors:  Julie B Sneddon; Qizhi Tang; Peter Stock; Jeffrey A Bluestone; Shuvo Roy; Tejal Desai; Matthias Hebrok
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

Review 6.  miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.

Authors:  Ying Zheng; Zhen Wang; Zhiguang Zhou
Journal:  Cell Mol Immunol       Date:  2017-03-20       Impact factor: 11.530

Review 7.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

8.  The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development.

Authors:  Alexandra I Ziegler; Melanie A Le Page; Mhairi J Maxwell; Jessica Stolp; Haoyao Guo; Abhirup Jayasimhan; Margaret L Hibbs; Pere Santamaria; Jacques F Miller; Magdalena Plebanski; Pablo A Silveira; Robyn M Slattery
Journal:  Diabetologia       Date:  2013-09-08       Impact factor: 10.122

9.  In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.

Authors:  Jinguo Wang; Sue Tsai; Afshin Shameli; Jun Yamanouchi; Gonnie Alkemade; Pere Santamaria
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 10.  Positive evidence for vitamin A role in prevention of type 1 diabetes.

Authors:  Somaye Yosaee; Maryam Akbari Fakhrabadi; Farzad Shidfar
Journal:  World J Diabetes       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.